Attention Aehr Investors: Take Action with Bronstein, Gewirtz & Grossman LLC for Potential Loss Recovery

Aehr Test Systems Faces Class Action Lawsuit New York, Dec. 8, 2024 /PRNewswire/ — Attorney Advertising Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Aehr Test Systems, Inc. (“Aehr” or “the Company”) (NASDAQ: AEHR) and certain of its officers. This lawsuit seeks…

Read More

Evolv Technologies Holdings Inc. Faces Securities Lawsuit: Shareholders Urged to Contact The Schall Law Firm

The Schall Law Firm Reminds Investors of Class Action Lawsuit Against Evolv Technologies Holdings, Inc. LOS ANGELES, CA / ACCESSWIRE / December 8, 2024 The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Evolv Technologies Holdings, Inc. (“Evolv” or “the Company”) (NASDAQ:EVLV) for violations of 10(b)…

Read More

Breaking the Silence: AbbVie’s Emotional Impact Report Sheds Light on Mental Health of Underrepresented CLL Cancer Patients

New Insights on Emotional Impact of Chronic Lymphocytic Leukemia Diagnosis Recent findings have shed light on the emotional experiences of Black, Hispanic, and Asian patients diagnosed with chronic lymphocytic leukemia (CLL). According to a report by AbbVie, these patients tend to have more negative emotional outlooks throughout their treatment journey. Understanding Chronic Lymphocytic Leukemia Chronic…

Read More

Take Action: The Schall Law Firm Urges Shareholders to Pursue Securities Fraud Case Against Five9 Inc.

Investors Alert: Class Action Lawsuit Against Five9, Inc. Background LOS ANGELES, CA / ACCESSWIRE / December 8, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Five9, Inc. (“Five9” or “the Company”) (NASDAQ:FIVN) for violations of 10(b) and 20(a) of the Securities Exchange Act…

Read More

Title: PACS Group Inc. Faces Securities Fraud Lawsuit: Affected Investors Urged to Contact The Schall Law Firm

The Schall Law Firm Files Class Action Lawsuit Against PACS Group, Inc. Overview LOS ANGELES, CA / ACCESSWIRE / December 8, 2024 The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against PACS Group, Inc. (“PACS” or “the Company”) (NYSE:PACS) for violations of the federal securities…

Read More

Discover the Power of Novartis’ Scemblix: Longer-Term Data Proves Superior Efficacy and Safety for Adults with Newly Diagnosed CML!

Welcome to the Future of CML Treatment! The latest news from Novartis Basel, December 8, 2024 Novartis has just released groundbreaking results from the Phase III ASC4FIRST trial, showcasing the superior efficacy of Scemblix® (asciminib) in treating Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase (Ph+ CML-CP) patients. The study compared Scemblix to standard-of-care tyrosine…

Read More

Revolutionizing R-R cHL Treatment: Affimed’s Acimtamig and AlloNK Combination Proves Safe and Effective for Relapsed/Refractory Classical Hodgkin Lymphoma Patients

Revolutionizing R-R cHL Treatment: Affimed’s Acimtamig and AlloNK Combination Proves Safe and Effective for Relapsed/Refractory Classical Hodgkin Lymphoma Patients MANNHEIM, Germany, Dec. 08, 2024 (GLOBE NEWSWIRE) — Affimed N.V. (Nasdaq: AFMD) Affimed, a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced the presentation of data in a…

Read More

AIXI Deadline: Investors Can Take the Lead in Xiao-i Corporation Securities Lawsuit

Rosen Law Firm Reminds Xiao-I Corporation Investors of December 16 Deadline NEW YORK, Dec. 8, 2024 /PRNewswire/ — Overview: Rosen Law Firm, a global investor rights law firm, is reminding purchasers of Xiao-I Corporation (NASDAQ: AIXI) about the upcoming lead plaintiff deadline on December 16, 2024. This deadline applies to investors who bought American depository…

Read More